Fluphenazine Hydrochloride Solution, Concentrate
FDA Label NDC 0121-0653

25 label sections · Submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Fluphenazine Hydrochloride (NDC 0121-0653). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding increased mortality in elderly patients with dementia-related psychosis, description, clinical pharmacology, indications and usage, contraindications, tardive dyskinesia, neuroleptic malignant syndrome (nms), falls, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.